Shanghai Pioneer Holding Ltd (HKG:1345)
2.260
+0.030 (1.35%)
Apr 24, 2025, 3:27 PM HKT
Shanghai Pioneer Holding Revenue
In the year 2024, Shanghai Pioneer Holding had annual revenue of 1.53B CNY, down -2.27%. Shanghai Pioneer Holding had revenue of 713.08M in the half year ending December 31, 2024, a decrease of -20.47%.
Revenue
1.53B CNY
Revenue Growth
-2.27%
P/S Ratio
1.61
Revenue / Employee
4.57M CNY
Employees
335
Market Cap
2.63B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1.53B | -35.62M | -2.27% |
Dec 31, 2023 | 1.57B | 10.63M | 0.68% |
Dec 31, 2022 | 1.56B | 121.22M | 8.45% |
Dec 31, 2021 | 1.43B | 102.78M | 7.72% |
Dec 31, 2020 | 1.33B | 16.06M | 1.22% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BeiGene | 29.60B |
Hansoh Pharmaceutical Group Company | 13.05B |
JD Health International | 61.89B |
WuXi Biologics | 19.87B |
Innovent Biologics | 10.03B |
Akeso | 2.26B |
Alibaba Health Information Technology | 31.39B |
CSPC Pharmaceutical Group | 30.87B |